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Abstract Reg is a growth factor with mitogenic e¡ects on
pancreatic L cells and gastric stem cells. To date, there has
been no information available on Reg-mediated intracellular
signal transduction pathways. The role of Reg in the gastric
carcinogenesis is also unknown. In the current study, the Reg
signaling pathway in gastric cancer cell was examined. Reg
treatment of MKN45 gastric cancer cells resulted in tyrosyl-
phoshorylation of several cellular proteins and subsequent acti-
vation of classical MAPK, ERK1/2. Reg also stimulated thymi-
dine incorporation in MKN45 and AGS gastric cancer cells in a
dose-dependent manner. Finally, Reg was shown to be highly
expressed in a large number of gastric cancers in vivo. Taken
together, these data suggest that gastric cancer cells have gained
the ability to overexpress Reg protein, which confer upon them-
selves added proliferative capacities, resulting in a considerable
growth advantage.
. 2002 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
In 1988, Reg (regenerating gene) was isolated as a gene up-
regulated in regenerating pancreatic islet cells, utilizing a dif-
ferential hybridization technique [1]. The Reg gene product,
Reg was a lectin-related secretory protein and was shown to
be mitogenic to isolated islet cells [2] and cells of a pancreatic
L cell line [3]. Thus, Reg is thought to be an endogenous
growth factor in pancreatic islets that presumably acts in an
autocrine or paracrine manner. On the other hand, Reg gene
expression has also been found outside the pancreas, mainly
in foregut-derived tissues. In particular, Reg was highly ex-
pressed in the gastric mucosa, at levels second only to those
observed in the pancreas, suggesting a critical role in gastric
mucosal proliferation [4]. A series of studies from our labora-
tory has focused on this issue. We have demonstrated that
Reg functions as a growth factor for gastric mucosal stem
cells and that it is involved in various important phenomena
in the stomach, such as hypergastrinemia and mucosal regen-
eration [5^7].
Despite these advances, two important issues remain un-
clear. First, how is the Reg signal transduced in a gastric
cell? Since the discovery of the Reg gene, no information
has been published on the signal transduction pathway
evoked by Reg. This is true not only for gastric cells, but
also for all other types of cells, including pancreatic L cells.
Secondly, it is interesting to hypothesize that Reg may be
involved in gastric carcinogenesis. In many cases, malignant
transformation results from aberrations in growth factor sig-
nal transduction pathways that normally operate to control
cell proliferation. A component of the pathway, either extra-
cellular [8] or intracellular [9,10], undergoes a qualitative or
quantitative change, leading to constitutive activation of the
growth signal and making the cell refractory to external con-
trol. Since Reg plays a central role in gastric stem cell prolif-
eration [5^7], an alteration of the Reg signal may contribute
to the neoplastic transformation of gastric stem cells.
Thus, the ultimate goals of our research are to delineate the
Reg-mediated signal transduction pathway in both normal
and cancerous gastric cells and to identify the segment of
the pathway altered in the neoplastic process. This could un-
cover novel mechanisms underlying carcinogenesis in gastric
tissue. As a ¢rst step towards this goal, we investigated
whether gastric cancer cells proliferate in response to extracel-
lular Reg stimuli as normal stem cells do. We also examined
the nature of the intracellular signaling pathway evoked dur-
ing this stimulation. In the course of the study, we found that
gastric cancer cells have gained the ability to produce large
amounts of the Reg protein, which may act upon themselves
causing proliferation, presumably a¡ording them a consider-
able growth advantage.
2. Materials and methods
2.1. COS cells transfection and preparation of conditioned media
The vector used to express the rat Reg protein was constructed by
modifying the plasmid pEGFP (Promega, Madison, WI, USA), which
contains the green £uorescent protein (GFP) gene under the control of
the CMV promoter. The plasmid was digested by SacII and NotI (to
remove the GFP sequence), and ligated to the rat Reg cDNA frag-
ment obtained by RT-PCR from rat stomach RNA, or, self-ligated to
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yield the control plasmid. RT-PCR was performed as described below
using the following primers that contain the sequence £anking the rat
Reg coding region: 5P-GCAGAGATTGTTGACTTGCA-3P and 5P-
GATAGATGGTCTAGTTTCAC-3P.
To prepare conditioned media, we cultured COS7 in Dulbecco’s
modi¢ed Eagle’s medium supplemented with 10% fetal calf serum
(FCS) and transfected them at 30^50% con£uence in 9-cm dishes.
Transfection was performed using the standard calcium phosphate
precipitation method with 15 Wg of Reg expression plasmid or control
plasmid. The precipitates were removed after 6 h, and the cells were
further incubated for 48 h in 10 ml of fresh, serum-free media. The
conditioned media were then collected and stored frozen as a source
of recombinant Reg protein for use at the time of the assays for
phosphorylation or thymidine incorporation.
2.2. Culture of gastric cells
Cells of the gastric cancer cell lines MKN45 and MKN7 were
cultured in RPMI medium. AGS cells were cultured in Ham’s F12
medium. Both media were supplemented with 10% FCS. The cells
were split 36 h before the assay at the indicated cell density. The cells
were washed twice with serum-free RPMI media 12 h before the assay
and further incubated for 10 h in serum-free media. Then, the cells
were again washed, further incubated for 2 h, and assayed for phos-
phorylation or thymidine incorporation.
2.3. Phosphorylation assay
Media conditioned by Reg-transfected COS cells or mock-trans-
fected COS cells were diluted 100-fold with serum-free RPMI me-
dium. Media of the MKN45 cells or MKN7 cells cultured as de-
scribed above were aspirated, and the medium conditioned by
transfected COS cells was added immediately. At the end of the in-
cubation, the conditioned medium was aspirated, and ice-cold SDS^
PAGE sample bu¡er was added to each plate on ice to obtain cell
lysates. The samples were normalized for protein content, and pro-
teins were separated by electrophoresis on a 7.5% SDS^polyacryl-
amide gel and transferred to polyvinylidene £uoride (PVDF) mem-
branes. Membranes were blocked using 5% non-fat dried milk in Tris-
bu¡ered saline (pH7.2) and incubated for 3 h with anti-tyr(p) (py20)
(Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA). Immunore-
active bands were visualized by chemiluminescence.
In the assay for ERK activation, four plates of MKN45 cells or
MKN7 cells were prepared as described in Section 2.2. The media of
all four plates were aspirated, the medium conditioned by mock-trans-
fected COS cells was added, and cells were further incubated for 2 h.
Subsequently, the cell lysates were collected from one plate (0 min).
The media from the rest of the plates were aspirated and replaced by
the medium conditioned by Reg-transfected COS cells. After the in-
dicated periods (5 min, 10 min, and 15 min), cell lysates were col-
lected. Lysates of all four time points were normalized for protein
content and subjected to Western blot analysis as described above,
except that a 12% SDS^polyacrylamide gel was employed, and the
membrane was probed with a monoclonal anti-phosphorylated ERK
antibody (Santa Cruz Biotechnology, Inc.). Immunoreactive bands
were visualized by chemiluminescence. As a loading control, the nor-
malized lysates were subjected to Western blot analysis using a rabbit
polyclonal anti ERK1/2 antibody (Sigma, St. Louis, MO, USA). In
the neutralizing experiment, the Reg-conditioned medium was diluted
100-fold with serum-free RPMI medium. Then the medium was mixed
with 100 Wg of mouse monoclonal anti-Reg antibody or 3 mg of non-
speci¢c mouse IgG and 1 ml of protein A agarose beads and incuba-
ted overnight with gentle rocking. The beads were pelleted by centri-
fugation and discarded. The treated media were added to MKN45
cells as above, and after 10 min of incubation, the lysates were pre-
pared and subjected to Western blot analysis.
2.4. Thymidine incorporation
The media conditioned by Reg-transfected COS cells or mock-
transfected COS cells were diluted with serum-free RPMI medium
as indicated. The media of the gastric cells cultured as above were
aspirated and replaced by the conditioned medium. The cells were
further incubated for 24 h. 1 WCi/ml of [methyl-3H]thymidine (Amer-
sham Pharmacia Biotech Co., Buckinghamshire, UK) was added, and
the cells were incubated for an additional 6 h. Cells were harvested
onto a glass ¢ber ¢lter mat using a Cell Harvester (Inotech, Switzer-
land). After the ¢lter was dried, [methyl-3H]thymidine incorporation
was measured using a 1450 Microbeta scintillation counter (Wallac,
Oy, Turku, Finland). The three independent assays were performed in
quadruplicate.
2.5. RNA isolation and cDNA synthesis by reverse transcription
Total RNA was extracted by the acid guanidinium-phenol chloro-
form method using Isogen (Nippon Gene, Tokyo, Japan). Then, 10 Wg
of total RNA extracted from each cell line was reverse transcribed to
cDNA using a First Strand cDNA Synthesis kit (Toyobo, Tokyo,
Japan) and ampli¢ed directly by the PCR method employing LA-
Taq polymerase (Takara, Kyoto, Japan) in 25 cycles.
2.6. Immunohistochemistry and Western blot analysis of gastric tissues
Tissue slices of gastric cancer specimens were dehydrated in a
graded ethanol series and embedded in para⁄n. Tissue sections
were cut at a 50-Wm thickness and mounted on poly-L-lysine-coated
glass slides. After being stored at 20‡C, the slides were air-dried for 30
min, and the cells in the area corresponding to the tumor mass were
dissected and collected into microfuge tubes and extracted once with
xylene and twice with ethanol. The pellet was dissolved in RIPA bu¡-
er, boiled for 10 min and normalized for protein content. The samples
were subjected to SDS^PAGE on a 15% gel and transferred to a
PVDF membrane. The membrane was probed with anti-human Reg
monoclonal antibodies [4].
For immunohistochemistry, the cryostat samples were prepared on
glass slides at a 6-Wm thickness and ¢xed in 100% acetone at 4‡C for
10 min. Samples were incubated with normal goat serum for 30 min,
followed by incubation for 120 min with a monoclonal antibody [4]
that the recognized the human Reg protein. After being washed with
phosphate-bu¡ered saline, the sections were incubated with biotinyl-
ated goat anti-mouse IgG for 30 min. Bound antibody was detected
by the avidin^biotin^peroxidase method (ABC kit; Vector Laborato-
ries, Burlingame, CA, USA). Peroxidase activity was subsequently
detected by incubation with 3,3P-diaminobenzidine (Sigma, St. Louis,
MO, USA) in 0.05 M Tris^HCl for 10 min at room temperature,
followed by hematoxylin staining. After dehydration in a graded etha-
nol series, the sections were cleared in xylene.
3. Results
3.1. Reg induced tyrosyl phosphorylation of several proteins
and activation of ERK1/2 in gastric cancer cells
COS cells were transiently transfected with a rat Reg cDNA
expression plasmid. Release of a large amount of the Reg
protein into the conditioned medium was con¢rmed by West-
ern blot analysis with an anti-rat Reg monoclonal antibody
[11], and this medium served as the source of the Reg protein
(Fig. 1a). As a negative control, the medium conditioned with
COS cells transfected with the mock plasmid was also pre-
pared (Fig. 1a). These conditioned media were added to cul-
tures of cells of a poorly di¡erentiated gastric cancer cell line,
MKN45, and the phosphorylation state of the cellular pro-
teins was examined by immunoblotting with anti-phosphoty-
rosine antibodies (PY20). Tyrosine phosphorylation of several
proteins was enhanced as early as 2 min after Reg treatment
(Fig. 1b). Phosphorylation of three major proteins of molec-
ular masses 170, 125 and 47 kDa was markedly enhanced
(Fig. 1b). Of note, with increasing cell density, these proteins
became basally phosphorylated (compare lanes 1 and 3 of Fig.
1b).
To explore whether the ERK1/2 pathway [12,13] lies down-
stream of Reg signaling, the activation of kinases during Reg
stimulation was evaluated using the same experimental con-
ditions as outlined above. Lysates obtained 5 min, 10 min
and 15 min after Reg treatment were subjected to Western
blot analysis using an anti-phospho-ERK antibody to detect
phosphorylated (and therefore activated) forms of ERK pro-
teins. ERK1/2 activity was slightly increased 5 min after Reg
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treatment, peaked at 10 min, and declined after 15 min
(Fig. 1c).
In order to rule out the possibility that the observed e¡ects
were mediated by some other undetermined factors secreted in
the Reg-conditioned medium, we performed a neutralizing
experiment employing the anti-Reg antibody. The Reg-condi-
tioned medium was mixed with the anti-Reg monoclonal anti-
body and protein A beads and incubated overnight. Then, the
medium was cleared of the resulting immune complexes by
centrifugation and added to MKN45 cells as described above.
This Reg-depleted medium did not stimulate activation of
ERK1/2 (Fig. 1d, lane 3). As a control, Reg-conditioned me-
dium was also treated with an excess amount of non-speci¢c
mouse IgG, and was shown to retain its stimulating activity
(Fig. 1d, lane 4).
We also examined Reg-mediated signaling events in the
other cell line MKN7, which is derived from a well-di¡eren-
tiated gastric carcinoma. We could not observe obvious
changes in the tyrosyl-phosphorylation state of the cellular
proteins (Fig. 1e) nor ERK activation (Fig. 1f) in response
to Reg.
3.2. Reg-stimulated growth of gastric cancer cells
The MKN45 cancer cells stimulated by the Reg-conditioned
medium as in Fig. 1b,c were cultured for an additional 30 h
and assayed for cell proliferation using the thymidine incor-
poration method. Addition of Reg stimulated the growth of
MKN45 cells in a dose-dependent manner, reaching a maxi-
mum nearly two-fold that of basal levels (Fig. 2a). To exam-
ine whether ERK activation is required for Reg-mediated cell
growth, the MAPK/MEK inhibitor PD98059 was employed.
In the presence of PD98059, the rate of Reg-mediated growth
induction was signi¢cantly inhibited (Fig. 2b). Next, we inves-
tigated the e¡ects of Reg on AGS cells, which also originate
Fig. 1. Reg-mediated signal transduction in cells of the gastric cancer line MKN45. a: The source of the Reg protein. COS cells were transi-
ently transfected with a rat Reg cDNA expression plasmid or a control plasmid (mock), and the medium conditioned by these cells was col-
lected. The release of large amounts of Reg protein into the conditioned medium of the rat Reg cDNA-transfected cells was con¢rmed by
Western blot analysis with an anti-rat Reg monoclonal antibody. b: Tyrosine phosphorylation of cellular proteins in response to Reg in
MKN45 cells. The medium conditioned by Reg-expressing COS cells (Reg medium) (+) or by mock-transfected COS cells (mock medium) (3)
were diluted 100-fold with serum-free culture media and added to MKN45 gastric cancer cells seeded at the indicated cell density (per 9-cm
dish). After incubation for 2 min, cell lysates were prepared. Proteins were separated by SDS^PAGE and immunoblotted with an anti-phospho-
tyrosine monoclonal antibody. c: ERK1/2 activation in response to Reg stimulation in MKN45 cells. The mock medium was diluted 100-fold
with serum-free culture media, added to MKN45 gastric cancer cells seeded at a cell density of 105 per 9-cm dish, and cells were further incu-
bated for 2 h. Then, the media were replaced by the Reg medium, also diluted 100-fold. After incubation for the indicated periods (0 min,
5 min, 10 min, and 15 min), cell lysates were prepared. Proteins were separated by SDS^PAGE and immunoblotted with an anti-phospho-
ERK monoclonal antibody. The lower panel shows the immunoblot with the anti-ERK1/2 polyclonal antibody as the loading control. d: A
neutralizing experiment using the anti-rat Reg monoclonal antibody. Mock medium (lane 1), Reg medium (lane 2), Reg medium precleared
with the anti-Reg antibody (lane 3), or Reg medium treated with an excess amount of non-speci¢c mouse IgG (lane 4) were diluted 100-fold
and added to MKN45 gastric cancer cells seeded at a cell density of 105 per 9-cm dish. After incubation for 10 min, cell lysates were prepared
and subjected to Western blot analysis using an anti-phospho-ERK monoclonal antibody. The contaminated anti-Reg monoclonal antibody
and non-speci¢c mouse IgG were recognized and visualized by anti-mouse IgG-HRP, which was employed as the secondary antibody in the
Western blot analysis (lanes 3 and 4). The lower panel shows the immunoblot with the anti-ERK1/2 polyclonal antibody as a loading control.
e: Tyrosine phosphorylation of cellular proteins in response to Reg stimulation in MKN7 cells. Reg medium (+) or mock medium (3) was di-
luted 100-fold with serum-free culture media and added to cultures of MKN7 gastric cancer cells seeded at a cell density of 105 per 9-cm dish.
After incubation for 2 min, the cell lysates were prepared and analyzed by Western blot analysis with an anti-phosphotyrosine monoclonal anti-
body. f: ERK1/2 activation in response to Reg stimulation in MKN7 cells. The mock medium was diluted 100-fold with serum-free culture me-
dia and added to cultures of MKN7 gastric cancer cells seeded at a cell density of 105 per 9-cm dish, and further incubated for 2 h. Then, the
media were replaced by the Reg medium, also diluted 100-fold. After incubation for the indicated periods (0 min, 5 min, 10 min, and 15 min),
cell lysates were prepared. Proteins were separated by SDS^PAGE and immunoblotted with an anti-phospho-ERK monoclonal antibody. The
lower panel shows the immunoblot with the anti-ERK1/2 polyclonal antibody as a loading control.
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from a poorly di¡erentiated gastric carcinoma. Reg enhanced
thymidine incorporation in AGS cells, though levels were
6 150% of that observed in the control (Fig. 2c). Finally,
MKN7 cells were tested, and no increase in Reg-stimulated
thymidine incorporation was observed (Fig. 2d).
3.3. Reg protein is overexpressed in gastric cancer cells
To assess the expression of Reg in gastric cancer cells, cells
of the MKN45, AGS, and MKN7 lines were analyzed by RT-
PCR (Fig. 3a). MKN45 and AGS cells showed some level of
expression. No expression of Reg was detected under these
experimental conditions in the MKN7 cell line (Fig. 3a).
In order to provide in vivo evidence, Western blot analyses
with anti-human Reg monoclonal antibody [4] were per-
formed on nine gastric cancer samples (Fig. 3b). The cells in
the tumor masses were dissected from para⁄nized blocks and
analyzed for expression of the Reg protein. Five of nine tu-
mors showed signi¢cant levels of expression of the Reg pro-
tein. The variation of molecular masses of the Reg proteins
can be explained by the heterogeneity of their sugar chains
[4,14]. Immunohistochemical analyses were also performed.
Fig. 4 shows a representative section of a poorly di¡erentiated
adenocarcinoma. In the portion of normal tissue (Fig. 4b,c),
Reg immunostaining was detected only in the small cells lo-
cated at the bottom of the gastric pit, which may be ECL
cells, as previously shown in rat [5] and human tissue [15]
(Fig. 4b). A basally located population of chief cells is also
stained, though faintly, for the Reg protein in human tissue,
as reported in the previous report [15] (Fig. 4b). No stain was
detected in the other normal parts, including the neck zone,
which harbors the gastric stem cells from which poorly di¡er-
Fig. 2. Growth stimulation of cultured gastric cells in response to Reg. a,c,d: Reg medium or mock medium were diluted as indicated with the
serum-free culture media and added to cultured gastric cells MKN45 (a), AGS (c) or MKN7 (d). After incubation for 24 h, [3H]thymidine was
added to the medium and the incubation was continued for a further 6 h. The cells were collected and assayed for thymidine incorporation.
The amount of incorporated thymidine in the cells treated with the Reg medium relative to that of the cells treated with the mock medium is
shown. b: Reg medium or mock medium was diluted 100-fold with serum-free culture media and added to MKN45 cells in the presence of the
indicated concentrations of PD98059. After incubation for 24 h, [3H]thymidine was added to the medium and the incubation was continued for
a further 6 h. The cells were collected and assayed for thymidine incorporation. The amount of incorporated thymidine in the cells treated with
the Reg medium relative to that of the cells treated with the mock medium is shown.
Fig. 3. Expression of Reg in gastric cancers. a: RT-PCR analysis of
expression of Reg in cultured gastric cancer cells. b: Western blot
analysis for expression of the Reg protein in gastric cancers in vivo.
The cells corresponding to tumor masses were dissected from nine
samples of para⁄n-embedded gastric cancers. The samples were ex-
tracted with xylene and ethanol, and analyzed for the expression of
the Reg protein by Western blot analysis with an anti-human Reg
monoclonal antibody. Lane 1, normal gastric epithelium; lanes 2^5,
well-di¡erentiated adenocarcinoma; lanes 6^9, poorly di¡erentiated
adenocarcinoma; lane 10, signet ring cell adenocarcinoma.
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entiated adenocarcinomas presumably originate (Fig. 4c).
Strong expression of the Reg protein was found in the cancer
cells, as shown in Fig. 4d,e.
4. Discussion
In many cases, the intracellular signaling pathway for a
growth factor involves tyrosine kinases. Therefore, we hy-
pothesized that this is also the case for the Reg signaling
pathway. We tested this possibility and observed tyrosine
phosphorylation of several cellular proteins in response to
Reg treatment (Fig. 1b). The phosphorylation began within
2 min of stimulation. Recently, a 105-kDa protein was iso-
lated as a cellular Reg receptor from an expression cDNA
library [16]. As judged by sequence homology [17,18] this
protein belongs to the EXT family, the members of which
have glycosyl transferase activity to assemble peptide glycans
[19]. It is unlikely that this protein is located upstream of the
tyrosine kinases, which are activated very rapidly in response
to Reg. Therefore two distinct Reg signaling pathways may
exist. One is the growth signaling pathway in gastric cells
discovered and presented in this study, and the alternative
pathway is the one evoked by the 105-kDa receptor, which
may mediate other important e¡ects of Reg. About 10 min
after Reg treatment, ERK1/2, a member of the MAP kinase
family, was activated (Fig. 1c) [12,13]. Activation of the
ERK1/2 pathway is thought to result in transcriptional acti-
vation of several growth regulatory genes, ultimately leading
to cell proliferation [12,13]. The representative members of the
MAP kinase family are ERK1/2, JNK, and p38. Many intra-
cellular signaling pathways converge on one of these MAP
kinases [12,13]. The character of the signaling pathway can
Fig. 4. Immunohistochemical staining for the Reg protein in a poorly di¡erentiated adenocarcinoma. Sections of a poorly di¡erentiated adeno-
carcinoma (a^e) were stained with an anti-human Reg monoclonal antibody. a: Whole section of the lesion, including normal and cancerous
parts. b: Basal half of the normal part. c: Upper half of the normal part. d,e: Cancerous parts.
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be predicted by knowing which MAPK is selected. ERK1/2,
known as the classical MAPK, lies downstream of many
growth factor signaling pathways. In contrast, JNK and p38
mediate stress-induced apoptotic signals. We have also tested
the activity of JNK and p38; however, no activation of these
kinases was seen in response to Reg stimulation (data not
shown). Taken together, involving some tyrosine kinases
and ERK1/2, the Reg signaling pathway seems to have a
representative and classical nature as a signal transduction
pathway for a growth factor. This is the ¢rst report to delin-
eate an intracellular Reg signaling pathway in any type of cell.
We have demonstrated that some gastric cancer cells pro-
liferate in response to Reg stimulation. Reg stimulated thymi-
dine incorporation in cells of the gastric cancer cell lines
MKN45 and AGS (Fig. 2). As described above, Reg evoked
the growth signaling pathway that converges on the ERK1/2
pathway in the MKN45 gastric cancer cells. Thus, it is sug-
gested that these cancer cells have the ability to respond to the
Reg signal, which leads to cell proliferation. MKN7 cells,
which are derived from a well-di¡erentiated gastric carcino-
ma, did not respond to the Reg growth signal. It is speculated
that the gastric stem cells may have retained their responsive-
ness to Reg in the course of malignant transformation to
mainly undi¡erentiated carcinomas.
We have demonstrated that the Reg protein is highly ex-
pressed in some parts of gastric cancer cells in vivo (Figs. 3b
and 4). Taken together with the results presented in Fig. 2, the
data raise the possibility that gastric cancer cells produce Reg
proteins that act upon themselves causing proliferation. Dur-
ing the multistep neoplastic progression, the cancer cells might
acquire the ability to produce the Reg protein, resulting in a
considerable growth advantage and development of the ma-
lignant phenotype. The precise mechanisms by which the Reg
proteins are distributed among cancer cells remain to be elu-
cidated. We speculate that the distribution occurs in a para-
crine manner or through cell-to-cell contact. Consistent with
this speculation, basal tyrosine kinase activity was observed
when the cells were grown at a higher density (Fig. 1b, lane 3).
Also, MKN45 cells grow exponentially at a normal cell den-
sity in serum-free medium without adding any growth factors,
but cease to grow when cultured at a low cell density.
In conclusion, we began research to delineate the intracel-
lular Reg-mediated signal transduction pathway, and eventu-
ally found that, in gastric cancer cells, the extracellular part of
the pathway has undergone a quantitative change, which pre-
sumably leads to a growth advantage. In a future study, de-
lineation of the intracellular Reg signal will be completed, and
additional mechanisms that may have profound e¡ects on
gastric carcinogenesis will be uncovered.
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